FUROSEMIDE

Product NDC: 61919-442
11-digit product format: 619190442
Labeler code: 61919
Product ID: 61919-442_a8ea7cbf-8e51-cc9b-e053-2a95a90aa751
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: FUROSEMIDE
Dosage form: TABLET
Route: ORAL
Labeler: DIRECT RX
Application: ANDA076796
Marketing category: ANDA
Marketing start: 2014-01-01
Marketing end: 0000-00-00
Substance: FUROSEMIDE
Active strength: 20 mg/1
Pharmacologic classes: Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	61919-442		D	Discontinued by firm		2026-08-10
excluded package	package	61919-442	61919-442-30	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 32 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-442-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-442-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-442-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-442-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-442-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-442-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-442-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-442-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-442-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61919-442-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61919-442-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61919-442-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	61919-442-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	61919-442-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	61919-442-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	61919-442-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A076796-001	FUROSEMIDE	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26
A076796-002	FUROSEMIDE	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26
A076796-003	FUROSEMIDE	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A076796-001	AB
A076796-002	AB
A076796-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-002	FUROSEMIDE	40MG	TABLET / ORAL	AB	2004-03-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-003	FUROSEMIDE	80MG	TABLET / ORAL	AB	2004-03-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076796-001	FUROSEMIDE	20MG	TABLET / ORAL	AB	2004-03-26	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076796-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076796-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076796-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076796-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076796-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076796-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076796-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076796-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076796-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076796-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076796-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076796-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076796-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076796-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076796-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076796-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076796-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d80d3aff-3a63-4d7b-a2be-fd9388b04330	Product name	9	20250806
9061e89f-9c86-4196-b34b-886fc1673cc4	Product name	1	20140821

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-442-30	2025-01-31	C162847	48780-1	1030e365-2e53-111a-e063-dadaa90a10e2	FUROSEMIDE
61919-442-30	2024-01-30	C162847	48780-1	1030e365-2e53-111a-e063-dadaa90a10e2	FUROSEMIDE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61919-442-30	FUROSEMIDE	30 in 1 BOTTLE	TABLET	30		6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-442-30	EA - Each	61919-442	438df933-2318-4818-b0a5-d918d7f3d650	1	2014-11-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FUROSEMIDE	ACTIVE INGREDIENT	7LXU5N7ZO5	FUROSEMIDE TABLET [DIRECT RX]	1
FUROSEMIDE	ACTIVE MOIETY	7LXU5N7ZO5	FUROSEMIDE TABLET [DIRECT RX]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	FUROSEMIDE TABLET [DIRECT RX]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	FUROSEMIDE TABLET [DIRECT RX]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	FUROSEMIDE TABLET [DIRECT RX]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	FUROSEMIDE TABLET [DIRECT RX]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-442	FUROSEMIDE TABLET [DIRECT RX]	5	Legacy NDC, 1 package rows	20200626_9ec7808e-9201-4b8c-9790-d329320dc6c4.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 31 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Furosemide	FUROSEMIDE	REMEDYREPACK INC.	3d312ab0-589c-427b-84da-18887244bfc9	2026-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Cardinal Health 107, LLC	2a5bcf50-6d63-463a-915e-a72ea2e5f131	2026-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Major Pharmaceuticals	6be1addd-a811-47fc-8650-6870d661c234	2026-05-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	REMEDYREPACK INC.	7181e528-c862-4dd7-8446-9011e4c7312a	2026-04-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	bd45c963-a413-e9a1-e053-2a95a90a1438	2026-02-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	AvKARE	d4c532be-1f3f-60d3-e053-2995a90a98be	2026-01-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Northwind Health Company, LLC	f2b920b2-f8b3-1e6e-e053-2a95a90ae153	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	48d8f490-e9d1-4c95-ab2f-414d3f4a9df4	2025-08-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	c24489c3-65e0-44e3-a50a-8bb0672e8821	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	52e75604-5766-40e8-a13a-8c449e06ebda	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	12137a90-fb35-45d7-8984-0b04793d3e34	2025-08-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	PD-Rx Pharmaceuticals, Inc.	3ba730ab-90d4-478a-80b3-1ea3edb03e4d	2025-07-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Solco Healthcare LLC	6a0fb397-63ae-4fce-bddf-16a91b1b7a2f	2025-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NCS HealthCare of KY, LLC dba Vangard Labs	114f4f4f-536a-4658-8fd0-2dd8c029b19a	2024-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	25c0aded-ffcd-4145-a48c-76c5fb220f61	2024-08-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	6cbf3834-0433-4dc0-e053-2a91aa0a8f8a	2024-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	7316929d-413a-e78f-e053-2a91aa0a417e	2024-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	NuCare Pharmaceuticals,Inc.	73e5c8f3-32f8-114c-e053-2a91aa0ab500	2024-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Aphena Pharma Solutions - Tennessee, LLC	4b3e2e13-a657-4da5-b536-8ae0a26812e0	2024-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796
Furosemide	FUROSEMIDE	Bryant Ranch Prepack	3b028a3c-102a-40f1-820e-b187ff1e1803	2024-03-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076796 application number: ANDA076796

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7LXU5N7ZO5	FUROSEMIDE	54-31-9	FUROSEMIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310429	furosemide 20 MG Oral Tablet	PSN	9ec7808e-9201-4b8c-9790-d329320dc6c4	6
310429	furosemide 20 MG Oral Tablet	SCD	9ec7808e-9201-4b8c-9790-d329320dc6c4	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
61919-442-30	61919044230	30 TABLET in 1 BOTTLE (61919-442-30)	30 tablet	2015-01-01	0000-00-00	No	No	Current